External validity in translational biomedicine: understanding the conditions enabling the cause to have an effect
Abstract A spectre is haunting biomedical research: It appears that a substantial fraction of published research results cannot be reproduced, while spectacularly successful novel treatments developed in experimental models of disease too often fail in clinical trials. A reproducibility crisis has b...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-12-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.202114334 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Abstract A spectre is haunting biomedical research: It appears that a substantial fraction of published research results cannot be reproduced, while spectacularly successful novel treatments developed in experimental models of disease too often fail in clinical trials. A reproducibility crisis has been proclaimed, and bench‐to‐bedside translation appears to be lost in a “valley of death”. Both predicaments, non‐reproducibility and translational roadblocks, are connected: Why should we expect to successfully “trans‐late” results to humans, if already “cis‐lation”—that is, the generalization from one experimental setting to an identical or fairly similar one—often fails? |
|---|---|
| ISSN: | 1757-4676 1757-4684 |